A Prospective, Randomized, Controlled Trial of Preoperative Transarterial Chemoembolization for Resectable Large Hepatocellular Carcinoma

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Annals of Surgery

• Publication date

  2009-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/SLA.0b013e3181961c16PMID 19212170
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hepatoblastoma: 15-year experience and role of surgical treatment

  2011cited by this paper
• Adjuvant Intra-arterial Iodine-131-labeled Lipiodol for Resectable Hepatocellular Carcinoma: A Prospective Randomized Trial—Update on 5-Year and 10-Year Survival

  2008cited by this paper
• Neoadjuvant/Adjuvant/Chemoprevention Therapy and Tumor Downstaging

  2008cited by this paper
• Is Preoperative Transarterial Chemoembolization Needed for a Resectable Hepatocellular Carcinoma?

  2007cited by this paper
• Transarterial chemoembolization for hepatocellular carcinoma.

  2006cited by this paper
• Preoperative transcatheter arterial chemoembolization reduces long-term survival rate after hepatic resection for resectable hepatocellular carcinoma.

  2006influential reference
• The continuing challenge of hepatic cancer in Asia.

  2005cited by this paper
• Percutaneous Local Ablative Therapy for Hepatocellular Carcinoma: A Review and Look Into the Future

  2003cited by this paper
• Role of Preoperative Transcatheter Arterial Chemoembolization for Resectable Hepatocellular Carcinoma: Relation between Postoperative Course and the Pattern of Tumor Recurrence

  2003cited by this paper
• Management of hepatocellular carcinoma.

  2002cited by this paper
• Influence of preoperative transcatheter arterial chemoembolization on liver resection in patients with resectable hepatocellular carcinoma.

  2002cited by this paper
• Neoadjuvant and adjuvant therapy for resectable hepatocellular carcinoma: review of the randomised clinical trials.

  2002cited by this paper
• Circulating tumor cell mRNAs in peripheral blood from hepatocellular carcinoma patients under radiotherapy, surgical resection or chemotherapy: a quantitative evaluation.

  2001cited by this paper
• Neoadjuvant and adjuvant therapy for operable hepatocellular carcinoma.

  1999cited by this paper
• Hematogenous dissemination of hepatocytes and tumor cells after surgical resection of hepatocellular carcinoma: a quantitative analysis.

  1999cited by this paper
• The effect of preoperative transcatheter hepatic arterial chemoembolization on disease‐free survival after hepatectomy for hepatocellular carcinoma

  1999cited by this paper
• Semiquantification of circulating hepatocellular carcinoma cells by reverse transcriptase polymerase chain reaction.

  1997cited by this paper
• A Prospective Randomized Trial of the Preventive Effect of Pre‐operative Transcatheter Arterial Embolization against Recurrence of Hepatocellular Carcinoma

  1996influential reference
• Is preoperative hepatic arterial chemoembolization safe and effective for hepatocellular carcinoma?

  1996cited by this paper
• Preoperative transcatheter arterial chemoembolization for resectable large hepatocellular carcinoma: A reappraisal

  1995influential reference
• Management of hepatocellular carcinoma.

  1992cited by this paper
• Primary hepatocellular carcinoma.

  1991cited by this paper
• Adverse effects of preoperative hepatic artery chemoembolization for resectable hepatocellular carcinoma: A retrospective comparison of 138 liver resections

  1989cited by this paper

• ADV score plus FDG-PET as preoperative predictors of post-resection prognosis in patients with hepatocellular carcinoma ≥10 cm: a retrospective cohort validation study.

  2026cites this paper
• The impact of neoadjuvant therapy on postoperative outcomes in patients undergoing hepatectomies for hepatocellular carcinoma.

  2025cites this paper
• Efficacy and safety of neoadjuvant therapy for hepatocellular carcinoma with portal vein thrombosis: A meta‑analysis

  2025cites this paper
• Sesquiterpene Curzerenone Activates Apoptotic Signaling and Attenuates PI3K/AKT/mTOR Signaling in HepG2 Cells by Triggering Oxidative Stress

  2025cites this paper
• PERI-START: a phase II trial of perioperative TACE, tislelizumab, and lenvatinib in early-stage hepatocellular carcinoma.

  2025cites this paper
• Imaging-based prediction of early recurrence and neoadjuvant therapy outcomes for resectable beyond Milan HCC.

  2025cites this paper
• Limited survival benefit of preoperative transarterial chemoembolization in huge hepatocellular carcinoma due to the prognostic impact of satellite nodules: a retrospective cohort study

  2025cites this paper
• Efficacy and safety of preoperative TACE in hepatocellular carcinoma beyond Milan criteria: A propensity score matching analysis.

  2025cites this paper
• Preoperative Transarterial Chemoembolization for Resectable Single Hepatocellular Carcinoma: A Single-Center Cohort Study

  2025cites this paper
• Critical Update: AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma.

  2025cites this paper
• Advances in neoadjuvant therapy for hepatocellular carcinoma

  2025cites this paper
• Advances in Locoregional and Systemic Treatments for HCC.

  2025cites this paper
• Long-Term Prognostic Significance of TACE-Induced Complete Pathological Response in Patients with Hepatocellular Carcinoma Who Have Undergone Liver Transplantation

  2025cites this paper
• Neoadjuvant hepatic arterial infusion of oxaliplatin, fluorouracil, and leucovorin for resectable single large hepatocellular carcinoma

  2025cites this paper
• Long-Term Outcomes of Transarterial Chemoembolization plus Ablation versus Surgical Resection in Patients with Large BCLC Stage A/B HCC.

  2025cites this paper
• Exploratory prospective, randomized phase II study of neoadjuvant transcatheter arterial chemoembolization plus surgery versus surgery alone for large hepatocellular carcinoma (CSGO‐HBP‐005): Clinical Study Group of Osaka University, Hepato‐Biliary‐Pancreatic Group

  2024cites this paper
• Neoadjuvant targeted immunotherapy followed by surgical resection versus upfront surgery for hepatocellular carcinoma with macrovascular invasion: A multicenter study

  2024cites this paper
• Impact of preoperative transcatheter arterial chemoembolization (TACE) on postoperative long-term survival in patients with nonsmall hepatocellular carcinoma: a propensity score matching analysis

  2024cites this paper
• Role of preoperative transarterial chemoembolization (TACE) in intermediate‐stage hepatocellular carcinoma (Hong Kong liver cancer stage IIB)

  2024influential citation
• Lipiodol combined with drug-eluting beads versus drug-eluting beads alone for transarterial chemoembolization of hepatocellular carcinoma: a multicenter study.

  2024cites this paper
• Neoadjuvant therapy of sequential TACE, camrelizumab, and apatinib for single huge hepatocellular carcinoma (NEO-START): study protocol for a randomized controlled trial

  2024cites this paper
• Prognostic benefit of preoperative transarterial chemoembolization in upfront resectable large hepatocellular carcinoma: a multicentric propensity score based analysis of European high-volume centers.

  2024cites this paper
• Prospective comparative study between anterior approach and conventional approach right formal hepatic resection for large hepatocellular carcinom

  2024cites this paper
• Neoadjuvant therapies in resectable hepatocellular carcinoma: Exploring strategies to improve prognosis.

  2024cites this paper
• Effect of neoadjuvant transarterial chemoembolization followed by resection versus upfront liver resection on the survival of single large hepatocellular carcinoma patients: A systematic review and meta-analysis

  2024cites this paper
• Adjuvant and neoadjuvant therapies for hepatocellular carcinoma.

  2023cites this paper
• Safety and Survival Outcomes of Liver Resection following Triple Combination Conversion Therapy for Initially Unresectable Hepatocellular Carcinoma

  2023cites this paper
• Preoperative transarterial chemoembolization (TACE) + liver resection versus upfront liver resection for large hepatocellular carcinoma (≥5 cm): a systematic review and meta-analysis

  2023cites this paper
• Concerns about how to simultaneously determine microvascular invasion and pathological response after transarterial chemoembolization before hepatocellular carcinoma surgery

  2023cites this paper
• Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2022 Edition)

  2023cites this paper
• Reply to the commentary on “The efficiency of pathological response after preoperative transcatheter arterial chemoembolization for microvascular invasion and early tumor recurrence in hepatocellular carcinoma”

  2023cites this paper
• An integrated strategy for deciding open versus laparoscopic hepatectomy for resectable primary liver cancer

  2023cites this paper
• AASLD practice guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma.

  2023cites this paper
• Neoadjuvant intensity modulated radiotherapy for a single and small (≤5 cm) hepatitis B virus-related hepatocellular carcinoma predicted to have high risks of microvascular invasion: a randomized clinical trial

  2023cites this paper
• Pathologic assessment of hepatocellular carcinoma in the era of immunotherapy: a narrative review

  2023cites this paper
• From clinical variables to multiomics analysis: a margin morphology-based gross classification system for hepatocellular carcinoma stratification

  2023cites this paper
• Cirrhotic and non-cirrhotic huge hepatocellular carcinoma (≥ 10 cm): a comparative study of surgical management and follow-up treatment in a single institution

  2023cites this paper
• Evaluation of the use of a novel bioabsorbable polymer drug-eluting microsphere for transarterial embolization of hepatocellular neoplasia in dogs

  2022cites this paper
• Neoadjuvant Therapy for Hepatocellular Carcinoma

  2022cites this paper
• Guiding Value of Circulating Tumor Cells for Preoperative Transcatheter Arterial Embolization in Solitary Large Hepatocellular Carcinoma: A Single-Center Retrospective Clinical Study

  2022cites this paper
• Neoadjuvant transarterial chemoembolization (TACE) plus PD-1 inhibitor bridging to tumor resection in intermediate-stage hepatocellular carcinoma patients

  2022cites this paper
• Interventional Oncology

  2022cites this paper
• An Overview of Clinical Trials in the Treatment of Resectable Hepatocellular Carcinoma.

  2022cites this paper
• Postoperative Adjuvant Hepatic Arterial Infusion Chemotherapy With FOLFOX in Hepatocellular Carcinoma With Microvascular Invasion: A Multicenter, Phase III, Randomized Study

  2022cites this paper
• Preoperative transcatheter arterial chemoembolization and prognosis of patients with solitary large hepatocellular carcinomas (≥5 cm): Multicenter retrospective study

  2022cites this paper
• Efficacy and safety of preoperative transarterial chemoembolization for hepatocellular carcinoma: a systematic review and meta-analysis

  2022influential citation
• Exploratory study of microparticle transcatheter arterial chemoembolization combined with resection for huge hepatocellular carcinoma

  2022cites this paper
• Intraarterial Therapies for the Management of Hepatocellular Carcinoma

  2022cites this paper
• Development and validation of a novel online calculator for estimating survival benefit of adjuvant transcatheter arterial chemoembolization in patients undergoing surgery for hepatocellular carcinoma

  2021cites this paper
• The past, present and future of conversion therapy for liver cancer.

  2021cites this paper
• Development and validation of prognostic nomograms for single large and huge hepatocellular carcinoma after curative resection.

  2021cites this paper
• Impact of pathological response after preoperative transcatheter arterial chemoembolization (TACE) on incidences of microvascular invasion and early tumor recurrence in hepatocellular carcinoma: a multicenter propensity score matching analysis.

  2021cites this paper
• Preoperative Versus Postoperative Transarterial Chemoembolization on Prognosis of Large Hepatocellular Carcinoma

  2021cites this paper
• Transcatheter arterial chemoembolization followed by surgical resection for hepatocellular carcinoma: a focus on its controversies and screening of patients most likely to benefit

  2021influential citation
• Impact of preoperative TACE on incidences of microvascular invasion and long‐term post‐hepatectomy survival in hepatocellular carcinoma patients: A propensity score matching analysis

  2021cites this paper
• Sequential transcatheter arterial chemoembolization and portal vein embolization before right hemihepatectomy in patients with hepatocellular carcinoma.

  2020cites this paper
• Postoperative Adjuvant Transarterial Infusion Chemotherapy with FOLFOX Could Improve Outcomes of Hepatocellular Carcinoma Patients with Microvascular Invasion: A Preliminary Report of a Phase III, Randomized Controlled Clinical Trial

  2020cites this paper
• Retrospective analysis of the immunogenic effects of intra-arterial locoregional therapies in hepatocellular carcinoma: a rationale for combining selective internal radiation therapy (SIRT) and immunotherapy

  2020cites this paper
• Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition)

  2020cites this paper
• Sequential transcatheter arterial chemoembolization and portal vein embolization versus portal vein embolization alone before major hepatectomy for patients with large hepatocellular carcinoma: An intent-to-treat analysis.

  2019cites this paper
• Neutrophil-lymphocyte ratio predicts the therapeutic benefit of neoadjuvant transarterial chemoembolization in patients with resectable hepatocellular carcinoma

  2019cites this paper
• Postoperative adjuvant transarterial chemoembolization improves the prognosis of hepatocellular carcinoma patients with microvascular invasion: a systematic review and meta-analysis

  2019cites this paper
• Preoperative transcatheter arterial chemoembolization for surgical resection of huge hepatocellular carcinoma (≥ 10 cm): a multicenter propensity matching analysis

  2019cites this paper
• More Than a Rash: Recurrent Hepatocellular Carcinoma After Liver Transplantation

  2019influential citation
• Systematic review of the outcomes of surgical resection for intermediate and advanced Barcelona Clinic Liver Cancer stage hepatocellular carcinoma: A critical appraisal of the evidence

  2018cites this paper
• Postoperative adjuvant transarterial chemoembolization for multinodular hepatocellular carcinoma within the Barcelona Clinic Liver Cancer early stage and microvascular invasion.

  2018cites this paper
• Angio-Computed Tomograph-Guided Immediate Lipiodol Computed Tomograph for Diagnosis of Small Hepatocellular Carcinoma Lesions during Transarterial Chemoembolization

  2018cites this paper
• Selective internal radiation therapy (SIRT) before partial hepatectomy or radiofrequency destruction for treatment of hepatocellular carcinoma in cirrhotic patients: a feasibility and safety pilot study.

  2018cites this paper
• Curative salvage liver transplantation in patients with cirrhosis and hepatocellular carcinoma: An intention‐to‐treat analysis

  2018influential citation
• Significance of presence of microvascular invasion in specimens obtained after surgical treatment of hepatocellular carcinoma

  2018cites this paper
• Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China (2017 Edition)

  2018cites this paper
• ASO Author Reflections: Proposal of a New Preoperative Prognostic Model for Solitary Hepatocellular Carcinoma

  2018cites this paper
• ASO Author Reflections: Proposal of a New Preoperative Prognostic Model for Solitary Hepatocellular Carcinoma

  2018cites this paper
• Combined liver resection and transarterial chemoembolization versus liver resection alone for the management of solitary large exophytic hepatocellular carcinoma with extrahepatic arterial supply: is two always better than one?

  2018cites this paper
• Surgery-induced tumor growth in (metastatic) colorectal cancer.

  2017cites this paper
• Anterior Versus Conventional Approach for Resection of Large Right Lobe Hepatocellular Carcinoma

  2017cites this paper
• Transcatheter Arterial Chemoembolization to Treat Primary or Metastatic Liver Malignancies Policy

  2017cites this paper
• Prognostic effect of transarterial chemoembolization–induced complete pathological response in patients undergoing liver resection and transplantation for hepatocellular carcinoma

  2017cites this paper
• Medical Management of Hepatocellular Carcinoma.

  2017cites this paper
• Transcatheter Arterial Chemoembolization ( TACE ) to Treat Primary or Metastatic Liver Malignancies Policy # 00227

  2017cites this paper
• Management of people with intermediate-stage hepatocellular carcinoma: an attempted network meta-analysis.

  2017cites this paper
• Preoperative adjuvant transarterial chemoembolization cannot improve the long term outcome of radical therapies for hepatocellular carcinoma

  2017cites this paper
• Preoperative transcatheter arterial chemotherapy may suppress oxidative stress in hepatocellular carcinoma cells and reduce the risk of short-term relapse.

  2017cites this paper
• Quality Improvement Guidelines for Transarterial Chemoembolization and Embolization of Hepatic Malignancy.

  2017cites this paper
• Sequential tumor-directed and lobar radioembolization before major hepatectomy for hepatocellular carcinoma

  2017cites this paper
• Does neoadjuvant doxorubicin drug-eluting bead transarterial chemoembolization improve survival in patients undergoing liver transplant for hepatocellular carcinoma?

  2017cites this paper
• Liver resection for hepatocellular carcinoma ≥5 cm.

  2017cites this paper
• Preoperative transcatheter arterial chemotherapy may suppress oxidative stress in hepatocellular carcinoma cells and reduce the risk of short-term relapse

  2017cites this paper
• Role of Hepatectomy for Hepatocellular Carcinoma in the Era of Transplantation and Locoregional Therapy

  2017cites this paper
• The Negative Effect of Preoperative Transcatheter Arterial Chemoembolization on Long-Term Outcomes for Resectable Hepatocellular Carcinoma: A Propensity Score Matching Analysis

  2016cites this paper
• Liver Resection and Transplantation for Patients With Hepatocellular Carcinoma Beyond Milan Criteria

  2016cites this paper
• Absence of Benefit of Transcatheter Arterial Chemoembolization (TACE) in Patients with Resectable Solitary Hepatocellular Carcinoma

  2016influential citation
• Preoperative transarterial chemoembolization for resectable hepatocellular carcinoma in Asia area: a meta-analysis of random controlled trials

  2016influential citation
• Randomized clinical trial of chemoembolization plus radiofrequency ablation versus partial hepatectomy for hepatocellular carcinoma within the Milan criteria

  2016cites this paper
• Transcatheter Arterial Chemoembolization (TACE) as a Treatment for Primary or Metastatic Liver Malignancies

  2016cites this paper
• Resection of Hepatocellular Carcinoma

  2016cites this paper
• Interventional Oncology.

  2016cites this paper
• Transarterial chemoembolization for hepatocellular carcinoma: an evidence-based review of its place in therapy

  2015cites this paper
• PRACTICE GUIDELINE SERIES

  2015cites this paper
• Evidence Summary Focal Ablation 2: Transarterial embolization for Liver Cancer A Quality Initiative of the Program in Evidence-Based Care (PEBC), Cancer Care Ontario (CCO) Focal Tumour Ablation: Transarterial Chemoembolization for Hepatocellular Carcinoma

  2015cites this paper